Keyphrases
Vascular Function
100%
Pilot Randomized Controlled Trial
100%
Nifedipine
100%
T-type Calcium Channel
100%
Efonidipine
100%
Between-group
66%
Elderly People
66%
Endothelial Dysfunction
66%
L-type Calcium Channel Blocker
66%
Vascular Conductance
66%
Leg Blood Flow
66%
N-acetylcysteine
66%
Co-infusion
66%
Endothelium-dependent Vasodilation
66%
Mean Arterial Pressure
33%
Cardiovascular Disease
33%
Randomized Controlled Trial
33%
Blood Pressure
33%
Vasodilator
33%
Smooth muscle Cells
33%
Vascular Reactivity
33%
Flow Response
33%
Intra-arterial
33%
Muscle Biopsy
33%
Healthy Elderly
33%
Endothelial Function
33%
Vastus Lateralis muscle
33%
Calcium Channel Blockers
33%
Antioxidant
33%
Intra-arterial Infusion
33%
Endothelium-dependent
33%
Acetylcholine
33%
Endothelial Nitric Oxide Synthase (eNOS)
33%
Sodium Nitroprusside
33%
Endothelium-independent
33%
Vasoreactivity
33%
L-type Calcium Channel
33%
Animal Data
33%
T-type Calcium Channel Inhibition
33%
T-type Calcium Channel Blocker
33%
Medicine and Dentistry
Randomized Controlled Trial
100%
Leg
100%
Calcium Channel Blocking Agent
100%
L-Type Calcium Channel
100%
Nifedipine
100%
Efonidipine
100%
Calcium Channel T Type
100%
Infusion
66%
Endothelial Dysfunction
66%
Vasodilator Agent
66%
Leg Blood Flow
66%
Acetylcysteine
66%
Blood Pressure
33%
Cardiovascular Disease
33%
Vasodilatation
33%
Mean Arterial Pressure
33%
Upregulation
33%
Smooth Muscle Cell
33%
Muscle Biopsy
33%
Endothelial Function
33%
Vastus Lateralis Muscle
33%
Intraarterial Drug Administration
33%
Antioxidant
33%
Acetylcholine
33%
Endothelial Nitric Oxide Synthase
33%
Sodium Nitroprusside
33%
Blood Vessel Reactivity
33%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Calcium Channel T Type
100%
Calcium Channel Blocker
75%
Nifedipine
75%
Efonidipine
75%
Endothelial Dysfunction
50%
Vasodilator Agent
50%
Acetylcysteine
50%
Cardiovascular Disease
25%
Albendazole
25%
Antioxidant
25%
Acetylcholine
25%
Nitroprusside Sodium
25%
Endothelial Nitric Oxide Synthase
25%
Calcium Channel L Type
25%
Neuroscience
Randomized Controlled Trial
100%
T-Type Calcium Channel
100%
Calcium Channel Blocker
60%
Nifedipine
60%
L-Type Calcium Channel
60%
Vasodilators
40%
Acetylcysteine
40%
Acetylcholine
20%
Antioxidant
20%
Endothelial Nitric Oxide Synthase
20%
Sodium Nitroprusside
20%